Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Completed Phase 1 Trials for Azacitidine (DB00928)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00351975Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesTreatment